Please try another search
For the fiscal year ended 30 June 2020, Medigard Ltdrevenues decreased from A$14K to A$0K. Net income totaledA$265K vs. loss of A$854K. Revenues reflect Revenue fromcontracts with customers decrease from A$12K to A$0K. NetIncome reflects Employee benefits decrease of 87% to A$47K(expense), Consultancy fees decrease from A$165K (expense)to A$0K, Finance costs decrease of 85% to A$3K (expense).
Period Ending: | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0.01 |
Gross Profit | -0.15 | 0 | -0.03 | -0.02 |
Operating Income | -0.23 | -0.13 | -0.12 | -0.67 |
Net Income | -0.23 | 0.49 | -0.15 | -0.71 |
Period Ending: | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 0.04 | 0.02 | 0.09 | 0.12 |
Total Liabilities | 0.35 | 0.09 | 1.16 | 0.93 |
Total Equity | -0.31 | -0.08 | -1.07 | -0.81 |
Period Ending: | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -0.15 | -0.12 | -0.52 | -0.33 |
Cash From Investing Activities | 0 | 0 | ||
Cash From Financing Activities | 0.12 | 0.09 | 0.18 | -0 |
Net Change in Cash | -0.03 | -0.03 | -0.35 | -0.33 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review